In addition, T2DM is associated with an increased risk of stroke and mortality after stroke (79)
This compound, known as exenatide, mimics the effects of GLP-1, a hormone that plays a critical role in appetite suppression, insulin secretion and glucose metabolism
Readers should consult official regulatory guidance and qualified professionals for decision-making
Regarding the risks, there is no patent risk, as the core patent is expected to expire only after 2031
Your healthcare provider must complete their portion confirming medical necessity and appropriate diagnosis
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery